How to conduct clinical trials in an ethical and scientifically responsible manner<br><br>This book presents a methodology for clinical trials that produces improved health outcomes for patients while obtaining sound and unambiguous scientific data. It centers around a real-world test case--involvin
Bayesian Methods and Ethics in a Clinical Trial Design
- Year
- 1996
- Tongue
- English
- Leaves
- 322
- Series
- Wiley Series in Probability and Statistics
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
How to conduct clinical trials in an ethical and scientifically responsible manner
This book presents a methodology for clinical trials that produces improved health outcomes for patients while obtaining sound and unambiguous scientific data. It centers around a real-world test case--involving a treatment for hypertension after open heart surgery--and explains how to use Bayesian methods to accommodate both ethical and scientific imperatives.
The book grew out of the direct involvement in the project by a diverse group of experts in medicine, statistics, philosophy, and the law. Not only do they contribute essays on the scientific, technological, legal, and ethical aspects of clinical trials, but they also critique and debate each other's opinions, creating an interesting, personalized text.
Bayesian Methods and Ethics in a Clinical Trial Design
* Answers commonly raised questions about Bayesian methods
* Describes the advantages and disadvantages of this method compared with other methods
* Applies current ethical theory to a particular class of design for clinical trials
* Discusses issues of informed consent and how to serve a patient's best interest while still obtaining uncontaminated scientific data
* Shows how to use Bayesian probabilistic methods to create computer models from elicited prior opinions of medical experts on the best treatment for a type of patient
* Contains several chapters on the process, results, and computational aspects of the test case in question
* Explores American law and the legal ramifications of using human subjects
For statisticians and biostatisticians, and for anyone involved with medicine and public health, this book provides both a practical guide and a unique perspective on the connection between technological developments, human factors, and some of the larger ethical issues of our times.Content:
Chapter 1 Introduction (pages 1β18): Joseph B. Kadane
Chapter 2 Ethically Optimizing Clinical Trials (pages 19β63): Kenneth F. Schaffner
Chapter 3 Admissibility of Treatments (pages 65β113): Nell Sedransk
Chapter 4 Statistical Issues in the Analysis of Data Gathered in the New Designs (pages 115β125): Joseph B. Kadane and Teddy Seidenfeld
Chapter 5 Introduction to the Verapamil/Nitroprusside Study (pages 127β130): Joseph B. Kadane
Chapter 6 The Mechanics of Conducting a Clinical Trial (pages 131β143): Eugenie S. Heitmiller and Thomas J. J. Blanck
Chapter 7 The Verapamil/Nitroprusside Study: Comments on βThe Mechanics of Conducting a Clinical Trialβ (pages 145β150): John L. Coulehan
Chapter 8 Computational Aspects of the Verapamil/Nitroprusside Study (pages 151β158): Lionel A. Galway
Chapter 9 Being an Expert (pages 159β162): Thomas J. J. Blanck, Thomas J. Conahan, Robert G. Merin, Richard L. Prager and James J. Richter
Chapter 10 Issues of Statistical Design (pages 163β170): Nell Sedransk
Chapter 11 Operational History and Procedural Feasibility (pages 171β175): Joseph B. Kadane
Chapter 12 Verapamil versus Nitroprusside: Results of the Clinical Trial I (pages 177β210): Joseph B. Kadane and Nell Sedransk
Chapter 13 Verapamil versus Nitroprusside: Results of the Clinical Trial II (pages 211β219): Eugenie S. Heitmiller, Joseph B. Kadane, Nell Sedransk and Thomas J. J. Blanck
Chapter 14 The Law of Clinical Testing with Human Subjects: Legal Implications of the New and Existing Methodologies (pages 221β249): David Kairys
Chapter 15 Commentary I on βThe Law of Clinical Testing with Human Subjectsβ (pages 251β255): Dale Moore and A. John Popp
Chapter 16 Commentary II on βThe Law of Clinical Testing with Human Subjectsβ (pages 257β261): Katheryn D. Katz
Chapter 17 Author's Response to Commentaries I and II (pages 263β266): David Kairys
Chapter 18 Whether to Participate in a Clinical Trial: The Patient's View (pages 267β305): Lawrence J. Emrich and Nell Sedransk
Chapter 19 Epilogue (pages 307β310): Joseph B. Kadane
π SIMILAR VOLUMES
<b>A balanced treatment of the theories, methodologies, and design issues involved in clinical trials using statistical methods</b></p><p> There has been enormous interest and development in Bayesian adaptive designs, especially for early phases of clinical trials. However, for phase III trials, fre
<p>With new statistical and scientific issues arising in adaptive clinical trial design, including the U.S. FDA`s recent draft guidance, a new edition of one of the first books on the topic is needed. Adaptive Design Methods in Clinical Trials, Second Edition reflects recent developments and regulat
<p><span>Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials provides a practical introduction to unconditional approaches to planning randomised clinical trials, particularly aimed at drug development in the pharmaceutical industry. This book is aimed at providing guida
Although adaptive design methods are flexible and useful in clinical research, little or no regulatory guidelines are available. One of the first books on the topic, Adaptive Design Methods in Clinical Trials presents the principles and methodologies in adaptive design and analysis that pertain to a